Biotech

All Articles

AvenCell bags $112M to flip 'switchable' CAR-Ts in the medical clinic

.AvenCell Rehabs has actually gotten $112 million in set B funds as the Novo Holdings-backed biotech...

China- located biotech programs ph. 3 after seeing midstage eye information

.China-based Minghui Pharmaceutical has actually connected its thyroid eye illness procedure to a de...

Sangamo slashes time to market for Fabry gene treatment as FDA accepts accelerated confirmation deal

.Sangamo Therapeutics has actually determined a faster way to market for its own Fabry ailment prosp...

Otsuka's kidney illness drug enhances UPCR degrees in ph. 3 trial

.Otsuka Pharmaceutical's kidney condition medicine has reached the major endpoint of a period 3 test...

Roche scraps $120M tau prospect, returning liberties to UCB

.Roche has actually sent back the liberties to UCB's anti-tau antitoxin bepranemab, walking away fro...

Editas reinforces in vivo approach by means of $238M Genenvant contract

.Editas Medicines has signed a $238 million biobucks deal to mix Genevant Science's fat nanoparticle...

Combo end results, Vicodin overlook and also stellar safety

.Vertex has stated period 3 data on its near-approval pain drug applicant suzetrigine, elucidating e...

Angelini pens $360M biobucks treaty for ph. 1 human brain ailment drug

.Italy's Angelini Pharma has signed a $360 million biobucks treaty centered on a phase 1-stage brain...

Sage lays off one-half of R&ampD team and also agitates C-suite again

.Sage Rehabs' most recent effort to reduce its pipe and also workforce are going to observe a third ...

With stage 1 data, Atmosphere has an eye on early-stage bladder cancer cells

.Along with its lead prospect in a period 3 test for an uncommon eye cancer, Mood Biosciences is hop...